GlassScriptPhysician profile
Gurpreet Kaur
NPI 1902289663
$1,373.20
in general payments reported to CMS, 2019-2025
17 companies · $540 in 2025
The $540 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $122 · 2023: $487 · 2024: $225 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $373.42 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $319.25 | 2023-2025 | |
| Pfizer INC. | $194.48 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $149.21 | 2022-2025 | Farxiga, Airsupra |
| Novartis Pharmaceuticals Corporation | $49.53 | 2022-2024 | |
| Lilly USA, LLC | $42.71 | 2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $36.46 | 2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $36.24 | 2023-2025 | Repatha, Otezla, Repatha |
| Exact Sciences Corporation | $26.82 | 2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $22.55 | 2025 | Austedo Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.89 | 2024 | Jardiance |
| Tempus Ai, INC | $19.46 | 2024 | |
| Abbott Laboratories | $18.73 | 2025 | Freestyle Libre 3 |
| Medtronic, INC. | $16.61 | 2023 | Intellis Adaptivestim |
| Heartflow, INC. | $16.00 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.98 | 2023 | Xifaxan |
| Dexcom, INC. | $15.86 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.